Gerresheimer Presents Innovative Solutions at Interphex N.Y.

Date: 26 April 2012

Düsseldorf/Vineland, April 24, 2012 - Gerresheimer will be displaying its comprehensive range of tubular glass based primary packaging solutions at the Interphex 2012, which is taking place at the Javits Convention Center, N.

Y. on May 1 up to 3, 2012 (booth 1952).



“Gerresheimer is a strong partner to the pharma industry, delivering innovative packaging products of excellent quality that satisfy all requirements of safety and user friendliness“, said Mike Fischer, Vice President Sales, Tubular Glass Americas.

 

Demand for syringe systems has increased vastly as a result of the increasingly complex and varied requirements posed by the healthcare market, especially physicians and patients, to the pharma and healthcare industry. The Gerresheimer Group offers a comprehensive and innovative portfolio of pharmaceutical primary packaging products and is one of the leading experts in the development and manufacture of syringes made from glass and plastic (cyclic olefins). The ClearJectTM plastic syringe systems are manufactured by Gerresheimer’s Japanese partner Taisei Kako.



Gerresheimer manufactures glass pre-fillable syringes as bulk or ready-to-fill products. RTF®-brand ready-to-fill glass syringes can have multicolor printing, a laser-applied identity code and a tamper-evident closure system. They are also delivered to the pharma industry sterile, pre-assembled and, if desired, with baked-on siliconization.



Gerresheimer offers chemically tempered glass cartridges for use in conjunction with pen systems and auto-injectors.

Patients who use pen systems or auto-injectors on a daily basis and are familiar with the use of glass cartridges are aware of the breakage risk. Chemically tempered glass cartridges could offer these patients greater safety in future.



More:



    Gerresheimer Vineland

    Gerresheimer Tubular Glass Products

    Clearject™ Syringes



About Gerresheimer




Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.



Our Group realizes revenues of around one billion euros and has over 10,000 employees at 47 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.

600450 Gerresheimer Presents Innovative Solutions at Interphex N.Y. glassonweb.com

See more news about:

Others also read

Hawaii and Texas Top List of 20 States and D.C. Adding Construction Jobs Since November 2011 as Delaware and New York Trail; Vermont and Louisiana Led 19 States with One-Month Gain, D.
The Emirates Arena and Sir Chris Hoy Velodrome have just been completed, creating a new world class sporting landmark for Scotland.
The United States is honoring its role, to the best of its ability, as the world's locomotive, although despite the positive performance of the real estate market, America seems to be recovering slower than expected.
The EBRD is providing loans worth €110 million to Turkish glass manufacturer Trakya Cam A.Ş. that will expand its product range at home and in Bulgaria and also establish a presence on the Russian market, setting new standards in energy efficiency.
SAGE Electrochromics, Inc., a world leader in the development and manufacture of dynamic glass, located in Faribault, Minn., today announced it has filed a lawsuit in U.S.
Irving, Texas (PRWEB) December 18, 2012 - The global automotive glass industry experienced good growth over the last five years and is expected to grow moderately with a CAGR of 3% over the next five years (2012-2017) to reach revenue of approximately US $17 billion in 2017.

Add new comment